Gene linked with successful hypertension therapy:
This article was originally published in Clinica
Individuals with high blood pressure who have a particular variant of the adducin gene are twice as likely to avoid heart attacks and strokes if they take a diuretic medication, says a US research team. Screening for the Gly460Trp variant of the adducin gene, which affects the way in which the kidneys deal with salt and water balance, could help identify those especially likely to benefit for low-dose diuresis, report University of Washington researchers in The Journal of the American Medical Association (April 3).
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.